Affinage

MYL6B

Myosin light chain 6B · UniProt P14649

Length
208 aa
Mass
22.8 kDa
Annotated
2026-04-29
21 papers in source corpus 9 papers cited in narrative 9 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MYL6B encodes a myosin alkali essential light chain that arose by gene duplication from MYL6 and is expressed in both non-muscle cells and slow skeletal/cardiac muscle, where it incorporates into myosin II holoenzymes and modulates shortening velocity and isometric force generation (PMID:2304459, PMID:16884681). Its N-terminal lobe dictates isoform-specific subcellular sorting to sarcomeric A-bands in cardiomyocytes, and it binds the first IQ motif of IQGAP1 and IQGAP3 scaffold proteins (PMID:8856505, PMID:18587628, PMID:21299499). Within non-muscle myosin II, MYL6B bridges MDM2 and p53, promoting MDM2-mediated ubiquitination and proteasomal degradation of p53 in an ATPase-dependent manner, thereby suppressing apoptosis in hepatocellular carcinoma cells (PMID:29439719). MYL6B also drives epithelial–mesenchymal transition, proliferation, migration, and invasion in colorectal and lung cancer cells, and its expression is regulated by the circ_0114866/miR-653-5p ceRNA axis (PMID:33817240, PMID:39281569).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 1990 Medium

    Establishing that MYL6B is a distinct alkali light chain isoform with non-muscle expression resolved the question of whether multiple alkali MLC genes encode functionally divergent proteins beyond the known skeletal/cardiac forms.

    Evidence cDNA cloning, Northern/Southern blotting, and cross-species expression profiling

    PMID:2304459

    Open questions at the time
    • No functional assay distinguishing MYL6B from MYL6 at the protein level
    • Tissue-specific regulation of MYL6B transcription not defined
  2. 1996 High

    Demonstrating that MYL6B sorts to sarcomeric A-bands with isoform-specific efficiency, and that the N-terminal lobe controls this sorting, established the first structure–function relationship for MYL6B within the myosin holoenzyme.

    Evidence Chimeric cDNA expression with double epitope-tagging competition assay and confocal microscopy in cultured rat cardiomyocytes

    PMID:8856505

    Open questions at the time
    • Mechanism by which the N-terminal lobe achieves sorting selectivity not resolved at atomic level
    • Whether sorting differences translate into distinct contractile outputs in vivo unknown
  3. 2006 Medium

    Correlating MYL6B abundance with decreased maximal shortening velocity and increased isometric force in single muscle fibers provided the first direct evidence that this isoform tunes mechanical performance of myosin II.

    Evidence Single-fiber mechanics (Vmax, Po/CSA) with protein isoform quantification in pig diaphragm slow fibers

    PMID:16884681

    Open questions at the time
    • Correlative design; no gain/loss-of-function manipulation of MYL6B in intact fibers
    • Whether these mechanical effects hold in non-muscle myosin II contexts untested
  4. 2008 Medium

    Identifying MYL6B as a specific binding partner of the first IQ motif of IQGAP1 expanded its interactome beyond myosin heavy chains to cytoskeletal scaffolding proteins.

    Evidence Native gel electrophoresis with synthetic IQ-motif peptides of IQGAP1

    PMID:18587628

    Open questions at the time
    • Interaction shown only with isolated peptides; not confirmed by co-IP or in intact cells
    • Functional consequence of MYL6B–IQGAP1 binding unknown
  5. 2011 Medium

    Extending the MYL6B–IQGAP interaction to IQGAP3's first IQ motif established IQ-motif selectivity across the IQGAP family, though the physiological role remained untested in mammalian cells.

    Evidence Native gel electrophoresis with synthetic IQ-motif peptides from IQGAP2 and IQGAP3; review synthesis with yeast analogy

    PMID:21299499 PMID:21428964

    Open questions at the time
    • No mammalian cell-based validation of functional relevance (e.g., cytokinesis)
    • Affinity and stoichiometry of IQGAP–MYL6B complexes not quantified
  6. 2018 High

    Discovering that MYL6B, as part of non-muscle myosin II, bridges MDM2 and p53 to promote p53 ubiquitination and degradation revealed an unexpected ATPase-dependent role for a structural myosin subunit in oncogenic signaling.

    Evidence Co-IP, mass spectrometry, ubiquitination assay, blebbistatin-mediated ATPase inhibition, MYL6B knockout in HCC cell lines with apoptosis and clonogenic readouts

    PMID:29439719

    Open questions at the time
    • Structural basis for how MYL6B simultaneously contacts MDM2 and p53 unknown
    • Whether this mechanism operates in non-cancer physiological contexts untested
    • Relative contribution of MYL6B versus MYL6 in NMII-dependent p53 regulation not addressed
  7. 2020 Medium

    Linking MYL6B knockdown to reversal of EMT markers and suppression of proliferation/migration in rectal adenocarcinoma cells positioned MYL6B as a functional driver of epithelial–mesenchymal transition in cancer.

    Evidence siRNA knockdown with CCK-8, Transwell, flow cytometry, and Western blot for E-cadherin, N-cadherin, Vimentin in rectal adenocarcinoma cells

    PMID:33817240

    Open questions at the time
    • Downstream signaling pathway connecting MYL6B to EMT transcription factor activation not identified
    • Single cancer type tested; generalizability uncertain
  8. 2024 Medium

    Identifying circ_0114866/miR-653-5p as an upstream ceRNA axis that de-represses MYL6B provided the first regulatory circuit controlling MYL6B expression in cancer and confirmed its oncogenic role in vivo.

    Evidence Dual-luciferase reporter assay, qPCR, Western blot, functional assays, and xenograft tumor model in NSCLC

    PMID:39281569

    Open questions at the time
    • Whether miR-653-5p regulates MYL6B in normal tissue homeostasis unknown
    • Transcriptional regulation of MYL6B independent of miRNA sponging not explored

Open questions

Synthesis pass · forward-looking unresolved questions
  • The structural basis for MYL6B's specificity within NMII holoenzymes, the mechanism linking its ATPase-dependent function to MDM2–p53 complex formation, and its physiological roles outside cancer contexts remain unresolved.
  • No crystal or cryo-EM structure of MYL6B in complex with myosin heavy chain or MDM2/p53
  • In vivo genetic models (knockout/knock-in mice) for MYL6B are lacking
  • Relative functional redundancy with MYL6 not systematically addressed

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 3 GO:0098772 molecular function regulator activity 1
Localization
GO:0005856 cytoskeleton 2 GO:0005829 cytosol 1
Pathway
R-HSA-1643685 Disease 3 R-HSA-397014 Muscle contraction 2 R-HSA-5357801 Programmed Cell Death 2
Complex memberships
non-muscle myosin II (NMII)

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1990 MYL6B (MLC1sa) is a myosin alkali light chain isoform that arose by gene duplication from MLC3nm (MYL6), is expressed at the onset of myogenesis in vitro, and is detected in nonmuscle cells across multiple species, implying functional divergence among alkali MLC isoforms. cDNA cloning, Northern/Southern blotting, isoform-specific probes, expression profiling across species and tissues Molecular and cellular biology Medium 2304459
1996 MYL6B (MLC1sa) shows isoform-specific sorting to sarcomeric A-bands in cardiomyocytes with lower specificity than slow or fast skeletal isoforms; the N-terminal lobe of each isoprotein is responsible for the isoform-specific sorting pattern, as determined by chimeric cDNA expression. Double epitope-tagging competition assay, confocal microscopy, chimeric cDNA expression in cultured rat cardiomyocytes Journal of cell science High 8856505
2006 MYL6B (MLC1Sa) expression level is inversely correlated with maximal shortening velocity (Vmax) in single pig diaphragm slow fibers, and fibers expressing MLC1Sa but not MLC1Sb generate greater isometric force per cross-sectional area, indicating that MLC1Sa modulates both shortening velocity and force generation. Single-fiber mechanics (Vmax, Po/CSA measurement), protein isoform quantification by gel electrophoresis Archives of biochemistry and biophysics Medium 16884681
2008 MYL6B (Mlc1sa, myosin essential light chain) binds specifically to the first IQ motif of human IQGAP1, as demonstrated by native gel electrophoresis with synthetic IQ-motif peptides. Native gel electrophoresis with synthetic peptides corresponding to each IQ motif of IQGAP1 Molecular and cellular biochemistry Medium 18587628
2011 MYL6B (Mlc1sa) interacts with the first IQ motif of IQGAP3 in a transient manner, as shown by native gel electrophoresis; this interaction does not occur with IQGAP1's IQ2-4 or with S100B, establishing IQ-motif selectivity for MYL6B across IQGAP family members. Native gel electrophoresis with synthetic IQ-motif peptides from IQGAP2 and IQGAP3 Bioscience reports Medium 21299499
2011 MYL6B (Mlc1sa) interaction with IQGAP1 IQ1 is proposed to participate in cytokinesis by analogy with the S. cerevisiae IQGAP-like protein Iqg1p, which uses a similar myosin light chain interaction for cytokinesis; the mammalian significance remains speculative. Review/synthesis of native gel binding data and yeast genetic evidence Biochemical Society transactions Low 21428964
2018 MYL6B binds to both MDM2 and p53, facilitates MDM2-p53 interaction, and promotes ubiquitination and proteasomal degradation of p53; this activity requires MYL6B to function as part of non-muscle myosin II (NMII) holoenzymes, as inhibition of myosin II heavy chain ATPase activity blocks the p53-suppressive effect. Immunoprecipitation, mass spectrometry, co-immunoprecipitation, ubiquitination assay, myosin II ATPase inhibitor treatment (blebbistatin), MYL6B knockout in HCC cell lines, flow cytometry for apoptosis, clonogenic assay Journal of experimental & clinical cancer research : CR High 29439719
2020 MYL6B knockdown in rectal adenocarcinoma cells suppresses proliferation, migration, and invasion while promoting apoptosis; MYL6B loss increases E-cadherin and decreases N-cadherin and Vimentin expression, placing MYL6B as a driver of the epithelial-mesenchymal transition (EMT) process. siRNA knockdown, CCK-8 proliferation assay, Transwell migration/invasion assay, flow cytometry apoptosis, Western blot for EMT markers Open life sciences Medium 33817240
2024 circ_0114866 acts as a sponge for miR-653-5p, thereby de-repressing MYL6B expression; elevated MYL6B in turn promotes proliferation, invasion, migration, and EMT in NSCLC cells, placing MYL6B downstream of the circ_0114866/miR-653-5p axis. Dual-luciferase reporter assay, qPCR, Western blot, CCK-8, colony formation, Transwell, wound healing, xenograft tumor model Heliyon Medium 39281569

Source papers

Stage 0 corpus · 21 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1990 Characterization of human myosin light chains 1sa and 3nm: implications for isoform evolution and function. Molecular and cellular biology 56 2304459
2023 Towards the discovery of goat meat quality biomarkers using label-free proteomics. Journal of proteomics 31 36871648
2017 Proteome changes of beef in Nellore cattle with different genotypes for tenderness. Meat science 30 29289712
2011 IQ-motif selectivity in human IQGAP2 and IQGAP3: binding of calmodulin and myosin essential light chain. Bioscience reports 28 21299499
1996 The intracompartmental sorting of myosin alkali light chain isoproteins reflects the sequence of developmental expression as determined by double epitope-tagging competition. Journal of cell science 27 8856505
2018 MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development. Journal of experimental & clinical cancer research : CR 20 29439719
2011 The interaction of IQGAPs with calmodulin-like proteins. Biochemical Society transactions 18 21428964
2008 IQ motif selectivity in human IQGAP1: binding of myosin essential light chain and S100B. Molecular and cellular biochemistry 18 18587628
2018 A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity. Frontiers in genetics 14 30524470
2022 Transcriptome-based analysis of early post-mortem formation of pale, soft, and exudative (PSE) pork. Meat science 13 36126390
2013 Identification of candidate genes encoding an LDL-C QTL in baboons. Journal of lipid research 12 23596326
2006 Multiple isoforms of myosin light chain 1 in pig diaphragm slow fibers: correlation with maximal shortening velocity and force generation. Archives of biochemistry and biophysics 9 16884681
1999 Gender- and thyroid hormone-related transitions of essential myosin light chain isoform expression in rat soleus muscle during ageing. Acta physiologica Scandinavica 7 10632633
2023 Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers. Heliyon 6 37128318
2022 Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine. Biology 5 35625411
2023 Identification of mouse soleus muscle proteins altered in response to changes in gravity loading. Scientific reports 4 37737267
2020 MYL6B drives the capabilities of proliferation, invasion, and migration in rectal adenocarcinoma through the EMT process. Open life sciences 4 33817240
2024 Molecular signatures diversity unveiled through a comparative transcriptome analysis of longissimus dorsi and psoas major muscles in Hanwoo cattle. Animal biotechnology 3 39051919
2024 circ_0114866 promotes the progression and EMT of non-small cell lung cancer via miR-653-5p/MYL6B axis. Heliyon 2 39281569
2026 Proteomic analysis of the eating quality of humped cattle beef from Rikaze cattle under various cooking methods. Food chemistry: X 0 42028547
2024 Molecular characterization of human HSPCs with different cell fates in vivo using single-cell transcriptome analysis and lentiviral barcoding technology. Clinical and translational medicine 0 39538416